A prospective, multicenter case-control study published in PLoS Medicine in 2025 described the frequency and clinical characteristics of patients with a protracted post-Covid course and searched for risk factors for persistence vs. improvement of symptoms. The analyses showed that in two thirds of the patients who had a post-Covid syndrome 6-12 months after acute SARS-CoV-2 infection, symptoms persisted in the following months.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- From symptom to diagnosis
Lung carcinoma – Pancoast tumor
- From symptom to diagnosis
Abdominal pain – Intraductal papillary mucinous neoplasia
- IBDmatters - Advanced Therapeutic Treatments
Examinations and considerations before therapy
- Journal Club
Management of axial spondyloarthritis
- Multiple myeloma
DREAMM-7: Belamaf plus bortezomib and dexamethasone outperforms comparator therapy
- COPD
Better outcomes through patient education and integrated care
- Atopic dermatitis and allergies Atopic dermatitis and allergies
Type 2 inflammation and other factors
- Case Report